Eton Pharmaceuticals Inc
NASDAQ:ETON

Watchlist Manager
Eton Pharmaceuticals Inc Logo
Eton Pharmaceuticals Inc
NASDAQ:ETON
Watchlist
Price: 10.41 USD -1.79% Market Closed
Market Cap: 269m USD
Have any thoughts about
Eton Pharmaceuticals Inc?
Write Note

Eton Pharmaceuticals Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Eton Pharmaceuticals Inc
Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Eton Pharmaceuticals Inc
NASDAQ:ETON
Revenue
$31.4m
CAGR 3-Years
28%
CAGR 5-Years
129%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Revenue
$87.7B
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Revenue
$47.4B
CAGR 3-Years
1%
CAGR 5-Years
14%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Revenue
$60.1B
CAGR 3-Years
-4%
CAGR 5-Years
14%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Revenue
$63.2B
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Revenue
$40.9B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
7%

Eton Pharmaceuticals Inc
Revenue Breakdown

Breakdown by Geography
Eton Pharmaceuticals Inc

Not Available

Breakdown by Segments
Eton Pharmaceuticals Inc

Total Revenue: 31.6m USD
100%
Product Sales And Royalties: 26.1m USD
82.6%
License: 5.5m USD
17.4%

See Also

What is Eton Pharmaceuticals Inc's Revenue?
Revenue
31.4m USD

Based on the financial report for Jun 30, 2024, Eton Pharmaceuticals Inc's Revenue amounts to 31.4m USD.

What is Eton Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 5Y
129%

Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Eton Pharmaceuticals Inc have been 28% over the past three years , 129% over the past five years .

Back to Top